Findd.AI | $21,000,000 | (May 22, 2026)
CVRD Health | $5,000,000 | (May 22, 2026)
checker | $8,000,000 | (May 22, 2026)
Certified by Founder
Lodge
Oorja Bio
start up
United States
- Houston, Texas
- 22/05/2026
- Series A
- $30,000,000
Oorja's goal is to develop groundbreaking therapies for cardiopulmonary and fibrotic disorders that target the underlying pathophysiology of disease.
By addressing key pathways, our medicines promote cellular repair, reverse and or remodel fibrotic tissue, going beyond symptom management to establish a new therapeutic standard of care.
Our success is driven by an experienced team with a proven track record in pulmonary drug development, commercialization, and high-value transactions.
- Industry Biotechnology Research
- Website https://oorjabio.com/
- LinkedIn https://www.linkedin.com/company/oorja-bio/
Imperagen | $5,000,000 | (May 22, 2026)
Hark(1) | $700,000,000 | (May 22, 2026)
Dandelion Health | $14,000,000 | (May 22, 2026)
Century Health | $5,000,000 | (May 22, 2026)
LawX | $8,709,375 | (May 22, 2026)
Overwatch AI | $1,500,000 | (May 22, 2026)